ANAPLASTIC OLIGODENDROGLIOMA
Clinical trials for ANAPLASTIC OLIGODENDROGLIOMA explained in plain language.
Never miss a new study
Get alerted when new ANAPLASTIC OLIGODENDROGLIOMA trials appear
Sign up with your email to follow new studies for ANAPLASTIC OLIGODENDROGLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Kids on brain tumor drugs get Long-Term checkup
Disease control Recruiting nowThis study follows children who have already taken dabrafenib and/or trametinib for certain brain tumors. Researchers will monitor side effects and track growth over time. The goal is to understand the long-term safety of these medications in young patients.
Matched conditions: ANAPLASTIC OLIGODENDROGLIOMA
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 04:03 UTC
-
New pill takes on brain tumors: first human trial begins
Disease control Recruiting nowThis early-phase study tests an oral drug called ONC206 in 102 adults with brain tumors that have come back or are rare. The main goal is to find the safest dose and understand side effects. Participants take the drug by mouth on a weekly schedule, and researchers monitor for any…
Matched conditions: ANAPLASTIC OLIGODENDROGLIOMA
Phase: PHASE1 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 03:53 UTC
-
New hope for recurrent brain cancer? drug combo enters human testing
Disease control Recruiting nowThis early-phase study tests a new two-drug combination for adults whose high-grade glioma (a type of brain cancer) has come back after standard treatment. The drugs are a low, continuous dose of temozolomide (a chemotherapy pill) plus abexinostat (an experimental drug). The main…
Matched conditions: ANAPLASTIC OLIGODENDROGLIOMA
Phase: PHASE1 • Sponsor: University of Nebraska • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New combo therapy targets aggressive brain tumors in phase 2 trial
Disease control Recruiting nowThis study tests a more intense treatment for a fast-growing type of brain cancer called IDH wildtype glioma. It combines higher doses of radiation with the chemotherapy drug temozolomide to try to stop the tumor from growing longer. The trial will enroll 40 adults with this spec…
Matched conditions: ANAPLASTIC OLIGODENDROGLIOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:53 UTC